Q3 2018

Filed Nov 13, 2018 · 10-Q · 44 days after period end · 0001564590-18-029292

Q3 2018 · 10-Q

Revenue

$0.00

— vs Q3 2017

Net Income

-$2.76M

N/M vs Q3 2017

EPS Diluted

-$0.35

N/M vs Q3 2017

Operating Income-$2,764,341N/M

Operating Cash Flow

Same quarter

Metric	Q3 2018	Q3 2017	Q3 2016	Q3 2015
Revenue	$0.00	$0.00	$0.00	$329.80K
Net Income	-$2.76M	-$2.07M	-$1.96M	-$1.86M
EPS Diluted	-$0.35	-$0.42	-$0.04	-$0.05

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR